The Role of Ampligen in Strategic Therapeutic Intervention (STI) of Highly Active Anti-Retroviral Therapy (HAART): A Multi-Center, Randomized, Controlled Study of Ampligen Potentiation of the HAART-Free Interval.

Trial Profile

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of Highly Active Anti-Retroviral Therapy (HAART): A Multi-Center, Randomized, Controlled Study of Ampligen Potentiation of the HAART-Free Interval.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Apr 2013

At a glance

  • Drugs Rintatolimod (Primary)
  • Indications HIV infections; HIV-1 infections
  • Focus Therapeutic Use
  • Sponsors Hemispherx Biopharma
  • Most Recent Events

    • 13 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 26 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top